山东11.5万家药品经营企业、医疗机构入驻追溯平台

Core Insights - The "Qingyuan Action" has been launched in Shandong to address prominent issues in the pharmaceutical distribution sector, focusing on enhancing regulatory measures and ensuring public safety in medication use [1] Group 1: Regulatory Actions - The action targets five core pain points in the pharmaceutical distribution sector, including illegal drug sales, non-compliance in prescription drug sales, and online sales violations [1] - Strict measures are being implemented to combat counterfeit drugs and the illegal circulation of drugs through improper channels, thereby reducing quality and safety risks [1] - The initiative emphasizes the responsibility of enterprises, promoting legal awareness and compliance through education and warnings [1] Group 2: Monitoring and Compliance - The provincial drug monitoring system has adopted a comprehensive approach with full coverage, online monitoring, and coordinated cross-departmental regulation [1] - Over 3,000 regulatory personnel have been equipped with a dedicated app for drug traceability, enhancing the precision of both online and offline monitoring [1] - Continuous monitoring of online pharmaceutical sales is being conducted to promptly address any suspected illegal activities [1] Group 3: Traceability System - The province has established a comprehensive drug traceability system, with 115,000 pharmaceutical enterprises and medical institutions registered on the traceability platform, leading the nation in both the number and rate of registered entities [2]